ArticleJournal of cytology
Morphological Markers of Chromosomal Instability: A Useful Aid in Effusion Cytology.
Article in Journal of cytology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chromosomal instability (CI) is essential for carcinogenesis. Micronuclei (MN), nuclear budding (NB), chromatin bridge (CB), and multipolar mitosis (MPM) are the morphological markers of CI. These markers can be studied in the effusion fluids like pleural and ascitic fluid. This study aimed to analyze their significance in differentiating between benign and malignant pleural and ascitic effusion fluids. Materials and Methods: A prospective observational study was conducted on 100 pleural and ascitic effusion fluids, out of which 71 were benign and 29 were malignant. A total of 20 malignant cases were confirmed by cell block preparation and immunohistochemistry. Leishman-stained slides were screened under oil immersion (1000×) for MN, CB, NB, and MPM. The number of cells with each of these markers were counted per 1000 cells. The data were analyzed by calculating the mean, standard deviation (SD), and Student's Results: Mean (SD) of MN, CB, NB, and MPM in malignant effusion cytology were 9.01 (4.65), 0.8846 (1.07), 0.96 (1.24), and 0.92 (0097) per 1000 cells counted, whereas, the mean for benign were1.0 (0.90), 0.39 (0.54), 0.51 (0.65), and 0.50(0.73) per 1000 cells, respectively. The difference between benign and malignant effusion cytology and MN score came out to be statistically significant with a Conclusion: The markers of CI help to differentiate between malignant and benign effusion cytology in low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.